Form 4: H.B. Fuller CFO John Corkrean Reports Equity Transactions
Insider Transaction Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, reported the conversion of performance and restricted stock units into common stock and related tax withholdings.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), reported changes in his beneficial ownership of company securities.
- On January 24, 2026, Corkrean acquired 2,943 shares of common stock from performance stock unit conversion and 1,301 shares from restricted stock unit conversion, both at a price of $60.07 per share.
- An additional 116 shares of common stock were acquired due to dividend accruals during the vesting period, also at $60.07 per share.
- To cover taxes, 465 shares were withheld from the 1,301 shares issued, and 1,005 shares were withheld from 3,059 shares issued, totaling 1,470 shares withheld.
- Following these transactions, Corkrean directly beneficially owns 57,536 shares of H.B. Fuller common stock.
- He also holds various employee stock options totaling 267,076 shares with exercise prices ranging from $45.05 to $77.72, and phantom units convertible into 28,248.05 shares of common stock.
- Remaining restricted stock units include 2,852.64 units vesting from January 26, 2025, and 4,370.58 units vesting from January 27, 2026.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it reflects the vesting and conversion of equity awards, indicating the executive's continued participation in the company's equity compensation plans. The tax withholdings are a standard part of such transactions.
Positives
- Conversion of 2,943 performance stock units and 1,301 restricted stock units into common stock indicates vesting and potential achievement of performance targets.
- Acquisition of 116 shares through dividend accruals demonstrates the benefit of holding equity awards.
- The transactions were made pursuant to a Rule 10b5-1 plan, indicating pre-planned, routine equity management.
Negatives
- 1,470 shares of common stock were withheld to cover tax obligations related to the vesting and issuance of equity awards.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure of insider equity transactions, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive landscape for H.B. Fuller.
Stakeholder Impact
- Shareholders: Provides transparency into executive compensation and equity ownership, confirming management's vested interest in the company's performance.
- Employees: Reflects standard executive compensation practices, which can influence broader employee incentive structures.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Vesting start date for Employee Stock Option (Right-to-Buy) with exercise price $50.1. |
| 01/25/2019 | Vesting start date for Employee Stock Option (Right-to-Buy) with exercise price $53.57. |
| 01/24/2020 | Vesting start date for Employee Stock Option (Right-to-Buy) with exercise price $45.05. |
| 01/24/2021 | Vesting start date for Employee Stock Option (Right-to-Buy) with exercise price $48.35. |
| 01/27/2022 | Vesting start date for Employee Stock Option (Right-to-Buy) with exercise price $51.89. |
| 01/24/2023 | Vesting start date for Employee Stock Option (Right-to-Buy) with exercise price $72.94. |
| 01/24/2024 | Vesting start date for some Restricted Stock Units and Employee Stock Option (Right-to-Buy) with exercise price $68.17. |
| 01/26/2025 | Vesting start date for some Restricted Stock Units and Employee Stock Option (Right-to-Buy) with exercise price $77.72. |
| 01/24/2026 | Transaction date for conversion of Performance Stock Units and Restricted Stock Units, acquisition of dividend shares, and tax withholdings. |
| 01/27/2026 | Vesting start date for some Restricted Stock Units and Employee Stock Option (Right-to-Buy) with exercise price $64.28. |
| 01/26/2027 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $50.1 and expiration date for some Restricted Stock Units. |
| 01/27/2028 | Expiration date for some Restricted Stock Units. |
| 01/25/2028 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $53.57. |
| 01/24/2029 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $45.05. |
| 01/24/2030 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $48.35. |
| 01/27/2031 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $51.89. |
| 01/24/2032 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $72.94. |
| 01/24/2033 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $68.17. |
| 01/26/2034 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $77.72. |
| 01/27/2035 | Expiration date for Employee Stock Option (Right-to-Buy) with exercise price $64.28. |
Keywords
H.B. Fuller, FUL, John J. Corkrean, Form 4, insider transaction, beneficial ownership, equity awards, stock options, restricted stock units, performance stock units, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.